Jun 12, 2023
Oncotelic Launches PR Chatbot
May 16, 2023
Oncotelic Participating at 2023 BIO International Convention
Apr 24, 2023
Oncotelic Launches PDAO SEC Chatbot
Apr 19, 2023
Oncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model Technology
Apr 17, 2023
ONCOTELIC PROVIDES YE 2022 FINANCIAL RESULTS COMPARED TO YE 2021 PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATE
Apr 03, 2023
Oncotelic Announces Release of Pet2DAO Tokens (PDAO)
Mar 20, 2023
Oncotelic Announces Pet2DAO Website is Live
Mar 13, 2023
High Intra-Tumor TGF-β2 Predicts Poor Survival in Pediatric Cancer of the Brainstem
Feb 06, 2023
Oncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell Cancer
Jan 25, 2023
Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer
1
2
3
4
5
6
7
<<
<
>
>>
Copyright © 2021 Oncotelic Inc., a TGF ImmunoOncology Company. All rights reserved.
Privacy